Une pièce de l’histoire militaire canadienne arrive en Colombie-Britannique
SURREY, Colombie-Britannique, 10 nov. 2019 (GLOBE NEWSWIRE) — Le CN (TSX : CNR) (NYSE : CNI) est fier d’annoncer que le dernier […]
TSX News -
Keystone resumes crude oil deliveries
CALGARY, Alberta, Nov. 10, 2019 (GLOBE NEWSWIRE) — Media Advisory — TC Energy Corporation (TSX:TRP) (NYSE:TRP) (TC Energy) today announced that […]
TSX News -
Historic piece of Canadian military history arrives in BC
SURREY, British Columbia, Nov. 10, 2019 (GLOBE NEWSWIRE) — CN (TSX: CNR) (NYSE: CNI) is proud to announce today that […]
TSX News -
REMINDER/Conference Call Notice: Intertape Polymer Group Inc. Third Quarter 2019 Results
MONTREAL and SARASOTA, Fla., Nov. 10, 2019 (GLOBE NEWSWIRE) — Intertape Polymer Group Inc. (TSX:ITP)AN ACCOMPANYING PRESENTATION WILL ALSO BE […]
NextCure Presents Updated Clinical Data from NC318 Phase 1/2 Clinical Trial at the 34th Annual Meeting of Society for Immunotherapy of Cancer (SITC) and Announces Initiation of Phase 2 Portion of the Trial
NC318 was well toleratedSingle agent activity observed in multiple tumor types, including a CR and a PR in NSCLCInitiated Phase […]
New Studies Demonstrate the Predictive Value of the Vectra® Test in People Diagnosed with Rheumatoid Arthritis
SALT LAKE CITY, Nov. 09, 2019 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN), a global leader in precision medicine, […]
Genocea Preclinical Data at SITC Demonstrate that Inhibitory Neoantigens in an Otherwise Protective Vaccine Reverse Anti-Tumor Responses
ATLAS™ identifies naturally occurring neoantigen-specific inhibitory T cell responses that are augmented after vaccinationInhibitory T cell responses exacerbate tumor growthCAMBRIDGE, […]
Vaccinex Presents Updated Interim Data from a Phase 1b/2 Study of Pepinemab (VX15/2503) in Combination with Avelumab (BAVENCIO®) in Non-Small Cell Lung Cancer at the 34th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
ROCHESTER, N.Y., Nov. 09, 2019 (GLOBE NEWSWIRE) — Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage biotechnology company pioneering novel investigational antibody […]
Autolus Therapeutics Presents Preclinical Data on AUT06NG at the SITC Annual Meeting
LONDON, Nov. 09, 2019 (GLOBE NEWSWIRE) — Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell […]
Top Cannabis Products of 2019 Announced at the Sixth Annual Canadian Cannabis Awards
Following the first full year of legalization, over 31,000 consumer votes on lift.co determined the top cannabis flower and oil […]
